A carregar...

Profile of elotuzumab and its potential in the treatment of multiple myeloma

Although the introduction of novel drugs has improved outcome significantly in multiple myeloma (MM), many patients still eventually relapse. Monoclonal antibodies (mAbs) targeting MM-related antigens can complement currently available therapies. CS1 (also known as CD2 subunit 1, SLAMF7, CD319, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Lymphat Cancer
Main Authors: Liu, Yi-Chang, Szmania, Susann, van Rhee, Frits
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4438995/
https://ncbi.nlm.nih.gov/pubmed/26005365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S49780
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!